1. Home
  2. FRSH vs HTFL Comparison

FRSH vs HTFL Comparison

Compare FRSH & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshworks Inc.

FRSH

Freshworks Inc.

HOLD

Current Price

$8.95

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

HTFL

Heartflow Inc.

HOLD

Current Price

$28.40

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSH
HTFL
Founded
2010
2007
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FRSH
HTFL
Price
$8.95
$28.40
Analyst Decision
Buy
Strong Buy
Analyst Count
15
5
Target Price
$14.86
$38.20
AVG Volume (30 Days)
9.9M
1.0M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
296.88
N/A
EPS
0.63
N/A
Revenue
$838,809,000.00
N/A
Revenue This Year
$16.30
$27.66
Revenue Next Year
$14.09
$23.55
P/E Ratio
$13.89
N/A
Revenue Growth
16.43
N/A
52 Week Low
$6.79
$20.13
52 Week High
$16.05
$41.22

Technical Indicators

Market Signals
Indicator
FRSH
HTFL
Relative Strength Index (RSI) 61.25 49.31
Support Level $7.65 $25.56
Resistance Level $9.19 $28.98
Average True Range (ATR) 0.33 1.56
MACD 0.04 -0.39
Stochastic Oscillator 81.50 9.07

Price Performance

Historical Comparison
FRSH
HTFL

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions. It derives maximum revenue from North America.

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.

Share on Social Networks: